Skip to Main Content

Writing Group Disclosures

Writing Group MemberEmploymentResearch GrantOther Research SupportSpeakers' Bureau/HonorariaExpert WitnessOwnership InterestConsultant/Advisory BoardOther
William T. Mahle Emory University School of Medicine None None None None None None None 
Robert H. Beekman III Cincinnati Children's Hospital Medical Center None None None None None AGA Medical Inc (Device Proctor)a; The Medicines Co (DSMC)a None 
Samuel S. Gidding Nemours Children's Clinic None None None None None None None 
Scott D. Grosse Centers for Disease Control and Prevention None None None None None None None 
Tracey R. Hoke University of Virginia None None None None None None None 
Robert Koppel Schneider Children's Hospital None None None None None None None 
G. Paul Matherne University of Virginia None None None None None None None 
Jane W. Newburger Boston Children's Heart Foundation None None None None None None None 
Frank C. Smith Pediatric Cardiology Associates of Central New York None None None None None None None 
Writing Group MemberEmploymentResearch GrantOther Research SupportSpeakers' Bureau/HonorariaExpert WitnessOwnership InterestConsultant/Advisory BoardOther
William T. Mahle Emory University School of Medicine None None None None None None None 
Robert H. Beekman III Cincinnati Children's Hospital Medical Center None None None None None AGA Medical Inc (Device Proctor)a; The Medicines Co (DSMC)a None 
Samuel S. Gidding Nemours Children's Clinic None None None None None None None 
Scott D. Grosse Centers for Disease Control and Prevention None None None None None None None 
Tracey R. Hoke University of Virginia None None None None None None None 
Robert Koppel Schneider Children's Hospital None None None None None None None 
G. Paul Matherne University of Virginia None None None None None None None 
Jane W. Newburger Boston Children's Heart Foundation None None None None None None None 
Frank C. Smith Pediatric Cardiology Associates of Central New York None None None None None None None 

This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (1) the person receives $10 000 or more during any 12-month period, or 5% or more of the person's gross income; or (2) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

a

Modest.

Close Modal

or Create an Account

Close Modal
Close Modal